Journals / Okmeydanı Tıp Dergisi / 2016 / Cilt: 32 - Sayı: 1

A Case of Hyperprolactinemia At Childhood

Çocukluk Çağında Bir Hiperprolaktinemi Olgusu

Pages
45–48
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In conclusion, medical treatment of prolactinoma in childhood may have satisfying response; so that medical treatment should be tried before surgical intervention.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Hyperprolactinemia is a rare disease in childhood which can originate from pituitary adenomas.
📊
Key Findings & Data:Laboratory evaluations revealed that, Thyroid Stimulating Hormone (TSH)=3.13 uIU/ml (0.5-5 uIU/ml), free T4=0.73 ng/dl (0.71-1.85 ng/dl), Follicule Stimulating Hormone (FSH)=10.7 mIU/ml (4-13 mIU/ml, follicular phase), Luteinising Hormone (LH)=8.45 mIU/ml, Prolaktin=227.9 ng/mL (5.18-26.53 ng/ml).
💡
Conclusion & Impact:In conclusion, medical treatment of prolactinoma in childhood may have satisfying response; so that medical treatment should be tried before surgical intervention.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Hyperprolactinemia is a rare disease in childhood which can originate from pituitary adenomas. Sixteen years old girl was admitted with complaints of amenorrhea and galactorrhea from left breast. On physical examination thyroid gland was nonpalpable and galactorrhea from left breast is detected. Laboratory evaluations revealed that, Thyroid Stimulating Hormone (TSH)=3.13 uIU/ml (0.5-5 uIU/ml), free T4=0.73 ng/dl (0.71-1.85 ng/dl), Follicule Stimulating Hormone (FSH)=10.7 mIU/ml (4-13 mIU/ml, follicular phase), Luteinising Hormone (LH)=8.45 mIU/ml, Prolaktin=227.9 ng/mL (5.18-26.53 ng/ml). Pituitary magnetic resonance imaging showed a macroadenoma about 20x15 mm extending to optic chiasm, enlarging sellaturcica and obliterating suprasellarcisterna. Serum levels of cortisole =14 mcg/dl (<20 mcg/dl), growth hormone=2.86 mIU/ml (0-20 mIU/ml), Adrenocorticotropic Hormone (ACTH)=24.7 pg/ml (0-100 pg/ml). There was no bitemporal defect in visual area examination. On neurosurgical consultation,there was no neccesity for surgical intervention and cabergoline treatment was initiated. Galactorrhea was resolved on the second day of treatment,and prolactin level decreased to 14.84 ng/ml on 7th day. Pituitary magnetic resonance imaging showed shrinkage in size of adenoma on 20th day. In conclusion, medical treatment of prolactinoma in childhood may have satisfying response; so that medical treatment should be tried before surgical intervention.

Özet

Hiperprolaktinemi çocukluk yaş grubunda ender olup, hipofiz adenomlarından kaynaklanabilir. On altı yaşında kız hasta âdet görememe, sol göğsünden süt gelmesi yakınmaları ile başvurdu. Fizik muayenesinde tiroid bezi palpe edilmeyen hastanın sol memesinden süt aktığı saptandı. Tetkiklerinde Tiroid Stimulan Hormon (TSH)=3.13 uIU/ml (0.5-5 uIU/ml), serbest T4=0.73 ng/dl (0.71-1.85 ng/dl), Folikül Stimulan Hormon (FSH)=10.7 mIU/ml (4-13 mIU/ml, foliküler faz), Lüteinizan Hormon (LH)=8.45 mIU/ml (2.4-12.6 mIU/ml), Prolaktin=227.9 ng/mL (5.18-26.53 ng/ml) bulunması üzerine çekilen hipofiz manyetik rezonans görüntülemede sella turcicayı genişleten, suprasellar sisterni oblitere eden, optik kiazmaya kadar uzanan 20x15 mm ebadında makroadenom saptandı. Kan Kortizol=14 mcg/dl (<20 mcg/dl), Büyüme Hormonu=2.86 mIU/ml (0-20 mIU/ml), Adrenokortikotropik Hormon (ACTH)=24.7 pg/ml (0-100 pg/ml) bulunan hastanın görme alanı muayenesinde bitemporal defekt izlenmedi. Nöroşirurji konsültasyonunda cerrahi girişim düşünülmeyen hastaya Kabergoline tedavisi başlandı. Tedavinin 2. gününde galaktoresi kaybolan olgunun 7. günde bakılan kan prolaktin düzeyi 14.84 ng/mL saptandı. Tedavinin 20. gününde çekilen hipofiz manyetik rezonans görüntülemede adenom boyutlarında küçülme tespit edildi. Sonuç olarak, çocuklarda hipofizer adenomların tedavisinde medikal tedavi ile yüz güldürücü sonuçlar alınabilir. Bu nedenle cerrahi girişimden önce medikal tedavi denenmelidir.

🔖

Cite This Article

YAŞA, B., KARABAYIR, N., ÖRMECİ, T., ÖCAL, Ö., ADAL, S. E. (2016). A Case of Hyperprolactinemia At Childhood. Okmeydanı Tıp Dergisi, Cilt: 32 - Sayı: 1, 45–48. https://ajindex.com/articles/340730

References (13)

  1. Lafferty AR, Chrousos GP. Pituitary tumors in children and adolescents. J Clin Endocrinol Metab 1999;84(12):4317-23. http://dx.doi.org/10.1210/jcem.84.12.6215
  2. Webb C, Prayson RA. Pediatric pituitary adenomas. Arch Pathol Lab Med 2008;132(1):77-80.
  3. Mindermann T, Wilson CB. Age-related and gender- related occurrence of pituitary adenomas. Clin Endoc- rinol 1994;41(3):359-64. http://dx.doi.org/10.1111/j.1365-2265.1994.tb02557.x
  4. Partington MD, Dudley HD, Laws ER et al. Pituitary ade- nomas in childhood and adolescence. Results of transs- phenoidal surgery. J Neurosurg 1994; 80(2):209-16. http://dx.doi.org/10.3171/jns.1994.80.2.0209
  5. Colao A, Loche S, Cappa M et al. Prolactinomas in child- ren and adolescents. Clinical presentation and long-term follow-up. J Clin Endocrinol Metab 1998;83(8):2777-80. http://dx.doi.org/10.1210/jcem.83.8.5001
  6. Catli G, Abaci A, Bober E et al. Clinical and diagnostic cha- racteristics of hyperprolactinemia in childhood and adoles- cence. J Pediatr Endocrinol Metab 2013;26(1-2):1-11. http://dx.doi.org/10.1515/jpem-2012-0327 Klibanski A. Clinical practice. Prolactinomas. N Engl J Med 2010;362(13):1219-26. http://dx.doi.org/10.1056/NEJMcp0912025
  7. Frieze TW, Mong DP, Koops MK. "Hook effect" in prolactinomas: case report and review of literature. En- docr Pract. 2002;8(4):296-303 http://dx.doi.org/10.4158/EP.8.4.296 Serri O. Progress in the management of hyperprolacti- nemia. N Engl J Med 1994;331(14):942-4. http://dx.doi.org/10.1056/NEJM199410063311412
  8. Chanson P, Salenave S. Diagnosis and treatment of pitui- tary adenomas. Minerva Endocrinol 2004;29(4):241-75.
  9. Vilar L, Freitas MC, Naves LA et al. Diagnosis and ma- nagement of hyperprolactinemia: results of a Brazilian multicenter study with 1234 patients. J Endocrinol In- vest 2008; 31(5):436-44. http://dx.doi.org/10.1007/BF03346388
  10. Melmed S, Casanueva FF, Hoffman AR et al. Diagno- sis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011;96(2):273-88. http://dx.doi.org/10.1210/jc.2010-1692
  11. Acharya SV, Gopal RA, Bandgar TR et al. Clinical pro- file and long term follow up of children and adolescents with prolactinomas. Pituitary 2009;12(3):186-9. http://dx.doi.org/10.1007/s11102-008-0149-8
  12. Panamonta O, Pakawut N. Galactorrhea in a 14-year- old girl. J Med Assoc Thai 2006;89(8):1304-7.
  13. Kreutzer J, Buslei R, Wallaschofski H et al. Operative treatment of prolactinomas: indications and results in a current consecutive series of 212